Early wound dehiscence with use of hydroxyapatite orbital implant covered with calf pericardium
Early wound dehiscence with use of hydroxyapatite orbital implant covered with calf pericardium
复制标题
使用小腿心包覆盖羟基磷灰石眼眶植入物治疗早期伤口裂开
DOI:
10.1136/bjo.85.5.625c
复制
发表时间:
2001
影响因子:
4.1
通讯作者:
Devron H. Char
中科院分区:
文献类型:
--
作者:
Devron H. Char
Editor,—Long acting periocular corticosteroids are commonly used to treat cystoid macular oedema (CMO) resulting from ocular inflammation or cataract surgery that does not respond to topical therapy. Drug localisation to the macular area is considered important for optimal therapeutic effect. In post-cataract CMO refractory to topical therapy, corticosteroids delivered by retrobulbar and posterior sub-Tenon's injections are equally effective.1 Steroids given by sub-Tenon's injection have previously been shown to localise to the macular area.2Retrobulbar anaesthetic injections have been shown to localise in the intraconal space, but not precisely to the macular area.34 We performed ultrasonography after retrobulbar steroid injection to confirm drug localisation in the macular area.
### CASE REPORT
Sixteen patients …